Advocacy intelligence hub — real-time data for patient organizations
Institute of Hematology & Blood Diseases Hospital, China — PHASE2
Novatim Immune Therapeutics (Zhejiang) Co., Ltd. — PHASE1
Mayo Clinic
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Sonoko Misawa, MD
Chiba University, Department of Neurology
Dao-bin Zhou, MD
Peking Union Medical College Hospital
Todd C Lee, MD MPH FIDSA
Research Institute of the McGill University Health Centre
Wei Wang, MD
Tongji Hospital
Frits van Rhee, MD
University of Arkansas
Jian Li, M.D.
Peking Union Medical College Hospital